EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosis

Clinical trial NCT02234843 · COMPLETED

Trial details

NCT number: NCT02234843
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Venous Thromboembolism

Start date: 2014-11-13
Primary completion: 2019-01-30
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.